Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
HTSUF Stock Price Chart
Explore Hisamitsu Pharmaceutical Co., Inc. interactive price chart. Choose custom timeframes to analyze HTSUF price movements and trends.
HTSUF Company Profile
Discover essential business fundamentals and corporate details for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
23 Sept 2010
Employees
2.76K
Website
https://www.hisamitsu.co.jpCEO
Kazuhide Nakatomi
Description
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
HTSUF Financial Timeline
Browse a chronological timeline of Hisamitsu Pharmaceutical Co., Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 8 Apr 2026
Upcoming earnings on 7 Jan 2026
Upcoming earnings on 9 Oct 2025
Earnings released on 10 Jul 2025
EPS came in at $0.24 falling short of the estimated $0.48 by -48.92%, while revenue for the quarter reached $240.61M , missing expectations by -9.96%.
Earnings released on 10 Apr 2025
EPS came in at $0.74 , while revenue for the quarter reached $296.88M , missing expectations by -99.21%.
Dividend declared on 10 Apr 2025
A dividend of $0.42 per share was announced, adjusted to $0.42.
Dividend declared on 10 Apr 2025
A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend will be paid on 1 Nov 2025.
Earnings released on 9 Jan 2025
EPS came in at $0.42 , while revenue for the quarter reached $238.94M .
Earnings released on 10 Oct 2024
EPS came in at $0.40 , while revenue for the quarter reached $270.84M .
Earnings released on 11 Jul 2024
EPS came in at $0.41 surpassing the estimated $0.28 by +46.37%, while revenue for the quarter reached $227.61M , missing expectations by -1.89%.
Earnings released on 11 Apr 2024
EPS came in at $0.16 , while revenue for the quarter reached $258.27M .
Dividend declared on 11 Apr 2024
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 23 May 2025.
Dividend declared on 11 Apr 2024
A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 29 Aug 2024.
Earnings released on 11 Jan 2024
EPS came in at $0.33 , while revenue for the quarter reached $243.00M .
Earnings released on 30 Aug 2023
EPS came in at $0.38 , while revenue for the quarter reached $238.87M , missing expectations by -48.07%.
Earnings released on 31 May 2023
EPS came in at $0.37 surpassing the estimated $0.14 by +168.18%, while revenue for the quarter reached $230.24M , beating expectations by +3.50%.
Dividend declared on 13 Apr 2023
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 24 May 2024.
Dividend declared on 13 Apr 2023
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 7 Nov 2023.
Earnings released on 28 Feb 2023
EPS came in at $0.21 , while revenue for the quarter reached $267.40M .
Earnings released on 12 Jan 2023
EPS came in at $37.88 , while revenue for the quarter reached $236.53M .
Earnings released on 12 Oct 2022
EPS came in at $61.11 , while revenue for the quarter reached $237.57M .
Earnings released on 7 Jul 2022
EPS came in at $20.45 surpassing the estimated $0.17 by +11.76K%, while revenue for the quarter reached $202.64M , missing expectations by -10.03%.
Earnings released on 7 Apr 2022
EPS came in at $43.08 , while revenue for the quarter reached $290.87M .
Dividend declared on 7 Apr 2022
A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 29 May 2023.
Dividend declared on 7 Apr 2022
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 9 Nov 2022.
Earnings released on 13 Jan 2022
EPS came in at $14.91 , while revenue for the quarter reached $248.59M .
Earnings released on 14 Oct 2021
EPS came in at $32.30 , while revenue for the quarter reached $280.07M .
Earnings released on 8 Jul 2021
EPS came in at $28.91 surpassing the estimated $20.80 by +38.99%, while revenue for the quarter reached $252.96M .
Earnings released on 8 Apr 2021
EPS came in at $43.16 , while revenue for the quarter reached $317.26M .
Dividend declared on 8 Apr 2021
A dividend of $0.36 per share was announced, adjusted to $0.36. The dividend was paid on 27 May 2022.
Dividend declared on 8 Apr 2021
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 11 Nov 2021.
Earnings released on 13 Jan 2021
EPS came in at $24.82 , while revenue for the quarter reached $267.94M .
Earnings released on 8 Oct 2020
EPS came in at $43.82 , while revenue for the quarter reached $264.14M .
Dividend declared on 10 Apr 2020
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 28 May 2021.
HTSUF Stock Performance
Access detailed HTSUF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.